These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 16200577)
41. Comment on: British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). McLaren ZL; Abernethy VE; Dawson JK Rheumatology (Oxford); 2009 Sep; 48(9):1178-9; author reply 1179. PubMed ID: 19578135 [No Abstract] [Full Text] [Related]
42. The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing. Landewé RB Arthritis Rheum; 2003 Jan; 48(1):1-5. PubMed ID: 12528097 [No Abstract] [Full Text] [Related]
43. [Prevention of deformation (disability) in rheumatoid arthritis]. Kriegbaum PE Ugeskr Laeger; 2000 Mar; 162(11):1578-9. PubMed ID: 10868122 [No Abstract] [Full Text] [Related]
48. [Long-term therapy with low dosage corticoids in rheumatology is well established]. Hatz HJ MMW Fortschr Med; 1999 Sep; 141(38):58-9. PubMed ID: 10904623 [No Abstract] [Full Text] [Related]
49. Combination DMARD therapy for rheumatoid arthritis. Full or low DMARD doses? Ferraccioli GF; Casatta L; Di Poi E; Damato R; Bartoli E Ann Rheum Dis; 1997 May; 56(5):336-7. PubMed ID: 9175939 [No Abstract] [Full Text] [Related]
50. Predictors of medication adherence in people with rheumatoid arthritis: studies are necessary but non-validated measures of medication adherence are of concern. Treharne GJ; Lyons AC; Hale ED; Douglas KM; Kitas GD Rheumatology (Oxford); 2005 Oct; 44(10):1330; author reply 1331. PubMed ID: 15972349 [No Abstract] [Full Text] [Related]
51. Sustained remission, possibly cure, of seronegative arthritis after high-dose chemotherapy and syngeneic hematopoietic stem cell transplantation. McColl GJ; Szer J; Wicks IP Arthritis Rheum; 2005 Oct; 52(10):3322. PubMed ID: 16200571 [No Abstract] [Full Text] [Related]
52. Clinical pharmacology of combination disease-controlling (DCART/DMARD) therapy in rheumatoid arthritis. Furst DE Z Rheumatol; 1998 Feb; 57(1):20-4. PubMed ID: 9566102 [No Abstract] [Full Text] [Related]
53. Psychological health and duration of treatment with second line antirheumatic medication: means to an end? Ward MM J Rheumatol; 1997 Nov; 24(11):2064-5. PubMed ID: 9375860 [No Abstract] [Full Text] [Related]
54. Interpretation of trial methodology not always easy: comment on the editorial by Landewé. Jacobs JW; Bijlsma JW Arthritis Rheum; 2003 Sep; 48(9):2693-4; author reply 2695. PubMed ID: 13130490 [No Abstract] [Full Text] [Related]
55. [Introducing "combination therapy"]. Rau R Z Rheumatol; 1998 Feb; 57(1):17-9. PubMed ID: 9566101 [No Abstract] [Full Text] [Related]
56. Combination drug therapy in rheumatoid arthritis. Russell AS; Ramos-Remus C J Rheumatol; 1997 Apr; 24(4):803-4. PubMed ID: 9101523 [No Abstract] [Full Text] [Related]